Aktivitas Enzim Metabolik Dalam Saliva Sebagai Penanda Biologis Penyakit Paru Obstruktif Kronik (PPOK)

  • Siti Sakdiah Poltekkes Kemenkes Jambi, Jambi, Indonesia
  • James Perdinan Simanjuntak Poltekkes Kemenkes Jambi, Jambi, Indonesia
  • Fardiah Tilawati Sitanggang Poltekkes Kemenkes Jambi, Jambi, Indonesia
  • Ahmad Syarthibi Poltekkes Kemenkes Jambi, Jambi, Indonesia
  • Tamrin Tamrin Poltekkes Kemenkes Jambi, Jambi, Indonesia
Keywords: PPOK, Enzim, Penanda Biologis, Saliva

Abstract

PPOK menjadi permasalahan kesehatan yang semakin mengkhawatirkan pada masyarakat di seluruh dunia. Usaha deteksi dini PPOK terus dikembangkan untuk mencegah perkembangan penyakit. Penggunaan parameter pemeriksaan laboratorium rutin dan sederhana dinilai berpotensi sebagai penanda perkembangan PPOK. Pengujian aktivitas enzim terhadap spesimen darah adalah parameter yang biasa diterapkan untuk diagnosis berbagai penyakit akut dan kronik. Pengujian tersebut belum dilakukan terhadap spesimen saliva dalam analisis rutin. Pengujian terhadap spesimen saliva masih sedikit dipelajari dan belum mendapat pengakuan sebagai parameter uji laboratorium. Sementara itu saliva diketahui memiliki kandungan enzim-enzim yang cukup tinggi dan telah dibuktikan keterkaitannya dengan perubahan kondisi pada penyakit-penyakit lainnya. Pengujian dilakukan untuk menganalisis profil enzim LDH, ALT, AST, GGT dan ALP sebagai penanda biologis untuk deteksi dini PPOK. Penelitian menggunakan desain case control dengan 20 responden PPOK dan 40 kontrol, terdiri dari 20 orang perokok aktif dan 20 orang bukan perokok. Saliva diperiksa aktivitas enzim menggunakan spektrofotometer di laboratorium kimia klinik jurusan TLM Poltekkes Kemenkes Jambi. Data dianalisis menggunakan Anova dan Benferonni. Hasil penelitian mendapatkan bahwa rata rata aktivitas ALT dan GGT signifikan lebih tinggi dibanding kontrol non PPOK perokok dan bukan perokok (p<0.05). Rata rata aktivitas LDH signifikan lebih rendah dibanding kontrol non PPOK perokok dan bukan perokok (p<0.05). Hasil analisis lebih lanjut membuktikan bahwa kelompok yang berbeda signifikan adalah aktivitas GGT dengan PPOK dan non PPOK bukan perokok. Rata-rata aktivitas AST dan ALP tidak berbeda signifikan antara ke 3 kelompok. Kesimpulan aktivitas LDH, ALT terutama GGT dalam saliva berpotensi sebagai penanda biologis untuk deteksi dini diagnosa PPOK.

Downloads

Download data is not yet available.

References

Bafadhel, M. et al. (2011) ‘Acute exacerbations of chronic obstructive pulmonary disease: Identification of biologic clusters and their biomarkers’, American Journal of Respiratory and Critical Care Medicine, 184(6), pp. 662–671. doi: 10.1164/rccm.201104-0597OC.

Bel, L. V et al. (2021) ‘Features of the Metabolic Profile of Saliva in Lung Cancer and COPD : The Effect of Smoking Status’.

Cepelak, I. et al. (2006) ‘Enzyme Catalytic Activities in Chronic Obstructive Pulmonary Disease’, Archives of Medical Research, 37(5), pp. 624–629. doi: 10.1016/j.arcmed.2006.01.004.

Choi, Y. J. et al. (2021) ‘Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males’, Scientific Reports, pp. 1–10. doi: 10.1038/s41598-021-94385-0.

Global Initiative for Chronic Obstructive Lung Disease. (2019). 2020 GOLD Report.https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2- 03Dec19_WMV.pdf

Hogea, S. P. et al. (2020) ‘Risk factors of chronic obstructive pulmonary disease exacerbations’, Clinical Respiratory Journal, 14(3), pp. 183–197. doi: 10.1111/crj.13129.

Kemenkes RI. Riskesdas 2013.
https://pusdatin.kemkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.p df

Kemenkes RI. Riskesdas 2018.
https://kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas- 2018_1274.pdf

Lasman, N. et al. (2020) ‘Baseline low ALT activity is associated with increased long-term mortality after COPD exacerbations’, BMC Pulmonary Medicine, 20(1), pp. 1–6. doi: 10.1186/s12890-020-1169-z.

Lõpez-Campos, J. L., Tan, W. and Soriano, J. B. (2016) ‘Global burden of COPD’, Respirology, 21(1), pp. 14–23. doi: 10.1111/resp.12660.

Luke, R. (2015) ‘Estimation of Specific Salivary Enzymatic Biomarkers in Individuals with Gingivitis and Chronic Periodontitis : A Clinical and Biochemical Study’, 7(July), pp. 54–57.

Mathers, C. D. and Loncar, D. (2006) ‘Projections of global mortality and burden of disease from 2002 to 2030’, PLoS Medicine, 3(11), pp. 2011–2030. doi: 10.1371/journal.pmed.0030442.

Mathur, S. (2020) ‘To Study Of Ldh Level In Chronic Obstructive Pulmonary Disease Patients’, pp. 80–81.

Melguizo-Rodríguez, L. et al. (2020) ‘Salivary biomarkers and their application in the diagnosis and monitoring of the most common oral pathologies’, International Journal of Molecular Sciences, 21(14), pp. 1–17. doi: 10.3390/ijms21145173.

Moon, J. Y. et al. (2018) ‘Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD)’, Expert Review of Proteomics, 15(11), pp. 923–935. doi: 10.1080/14789450.2018.1539670.

Nillawar, A. N., Bardapurkar, J. S. and Bardapurkar, S. J. (1803) ‘Evaluation of Alkaline phosphatase ( ALP ) and Heat Stable- ALP ( HS-ALP ) in Chronic Obstructive Pulmonary Disease ( COPD )’, 4(10), pp. 1803–1808.

Osiecki, H. and Gillis, M. (2008) ‘Chronic obstructive pulmonary disease’, Journal of Complementary Medicine, 7(2), pp. 14–20. doi: 10.1201/9781315382067-12.

Rajshekar, M., Tennant, M. and Thejaswini, B. (2014) ‘Salivary biomarkers and their applicability in forensic identification’, Sri Lanka Journal of Forensic Medicine, Science & Law, 4(1), p. 10. doi: 10.4038/sljfmsl.v4i1.6462.

Lee et al (2012) ‘Cigarette Smoking and Inflammation : Cellular and Molecular Mechanisms’, pp. 142–149. doi: 10.1177/0022034511421200.

Skopas, V. et al. (2021) ‘Lactate dehydrogenase isoenzymes in patients with acute exacerbation of chronic obstructive pulmonary disease: An exploratory cross-sectional study’, Respiratory Physiology and Neurobiology, 283(September), p. 103562. doi: 10.1016/j.resp.2020.103562.

Sun, D. et al. (2020) ‘Serum Levels of Gamma-Glutamyltransferase During Stable and Acute Exacerbations of Chronic Obstructive Pulmonary Disease’, pp. 1–7. doi: 10.12659/MSM.927771.

Sun, Z. et al. (2016) ‘Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology’, Biomarker Research, 4(1), pp. 1–13. doi: 10.1186/s40364-016-0065-4.

Tvarijonaviciute, A. et al. (2020) Saliva In Health And Disease : the present and future of a unique.

World Health Organisation (WHO) International Programme on Chemical Safety (IPCS) (1993) ‘Biomarkers and risk assessment: concepts and principles. Environmental Health Criteria 155’, Environmental Health Criteria, (155), p. 82. Available at: http://www.inchem.org/documents/ehc/ehc/ehc155.htm#SectionNumber:1.1.

World Health Organization. (2017). COPD Fact Sheet 2017 https://www.who.int/newsroom/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
Published
2022-11-20